Price · 10 years
Click the price chart to set a price alert
BioCryst Pharmaceuticals, Inc.
NASDAQ · EQUITY
$8.02 -$0.27 (-3.26%)
Click the price chart to set a price alert
Click the RSI chart to set an RSI alert
In the last 12 months, 1 member of Congress disclosed buying BCRX, most recently Gil Cisneros (trade on Jul 10, 2026, disclosed Sep 4, 2026).
| Traded | Member | Action | Amount | Disclosed |
|---|---|---|---|---|
| Jul 10, 2026 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Sep 4, 2026 |
| Nov 13, 2025 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Dec 15, 2025 |
Email Me When a Member of Congress Discloses a Trade in BCRX
What subscribers were emailed
Subscribers were emailed this on Sep 4, 2026.
From House and Senate members' STOCK Act disclosures. See which members pick the best stocks on the Congress stock trading leaderboard.
How much of each tracked fund's portfolio is in BCRX, from their latest 13F filings.
Loading fund ownership…
Revenue, margins, earnings, and cash flow for BCRX, from SEC filings.
Loading financials…
A fair-value estimate for BCRX you can set a price alert against.
Valuation is built on the same fundamentals feed as the Financials tab. Once it lands, the plan is to let you alert on the gap between price and fair value — not just on a price level.
Decision-first research for BCRX, with the full supporting analysis.
No research reports for BCRX yet.
Form 4/5 buys, sells, and grants reported by BCRX officers and directors.
Loading insider activity…
BioCryst Pharmaceuticals, Inc. (BCRX) has a live price chart, RSI(14), moving averages, and volume. Click the chart to set an email alert when price or RSI hits a level.
Private to you. Saved automatically as you type.
Sign up to keep notes on BCRX.